IL96747A0 - Oxazole derivatives and pharmaceutical compositions containing them - Google Patents
Oxazole derivatives and pharmaceutical compositions containing themInfo
- Publication number
- IL96747A0 IL96747A0 IL96747A IL9674790A IL96747A0 IL 96747 A0 IL96747 A0 IL 96747A0 IL 96747 A IL96747 A IL 96747A IL 9674790 A IL9674790 A IL 9674790A IL 96747 A0 IL96747 A0 IL 96747A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- oxazole derivatives
- oxazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/46—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL11240895A IL112408A0 (en) | 1989-12-20 | 1995-01-20 | Oxazole derivatives and pharmaceutical compositions containing them |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45354889A | 1989-12-20 | 1989-12-20 | |
| US58002190A | 1990-09-10 | 1990-09-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL96747A0 true IL96747A0 (en) | 1991-09-16 |
Family
ID=27037150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL96747A IL96747A0 (en) | 1989-12-20 | 1990-12-20 | Oxazole derivatives and pharmaceutical compositions containing them |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0434034A1 (ko) |
| JP (1) | JPH04217966A (ko) |
| KR (1) | KR910011810A (ko) |
| CN (4) | CN1028173C (ko) |
| CA (1) | CA2032674A1 (ko) |
| FI (1) | FI906213A (ko) |
| HU (2) | HU206100B (ko) |
| IL (1) | IL96747A0 (ko) |
| NO (1) | NO905444L (ko) |
| NZ (1) | NZ236474A (ko) |
| PT (1) | PT96276A (ko) |
| YU (1) | YU240990A (ko) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5187188A (en) * | 1992-04-03 | 1993-02-16 | Bristol-Myers Squibb Company | Oxazole carboxylic acid derivatives |
| US5348969A (en) * | 1992-04-03 | 1994-09-20 | Bristol-Myers Squibb Company | Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors |
| US5254576A (en) * | 1992-04-03 | 1993-10-19 | Bristol-Myers Squibb Company | Diphenyl-heterocyclic-oxazole as platelet aggregation inhibitors |
| US5362879A (en) * | 1993-04-15 | 1994-11-08 | Bristol-Myers Squibb Company | 4-5-diphenyloxazole derivatives as inhibitors of blood platelet aggregation |
| DE4330959A1 (de) * | 1993-09-09 | 1995-03-16 | Schering Ag | Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
| CN1046714C (zh) * | 1993-12-20 | 1999-11-24 | 藤泽药品工业株式会社 | 二芳基噁唑衍生物及其制法、应用和药物组合物 |
| TW401408B (en) * | 1995-07-21 | 2000-08-11 | Fujisawa Pharmaceutical Co | Heterocyclic compounds having prostaglandin I2 agonism |
| JP4345230B2 (ja) * | 1998-03-10 | 2009-10-14 | 小野薬品工業株式会社 | カルボン酸誘導体およびその誘導体を有効成分として含有する薬剤 |
| PE20060362A1 (es) * | 2004-05-24 | 2006-05-15 | Irm Llc | Compuestos de oxazol como moduladores de ppar |
| US20080292608A1 (en) * | 2005-11-07 | 2008-11-27 | Irm Llc | Compounds and Compositions as Ppar Modulators |
| JP6095580B2 (ja) | 2012-02-13 | 2017-03-15 | 武田薬品工業株式会社 | 芳香環化合物 |
| JP6121339B2 (ja) | 2012-02-13 | 2017-04-26 | 武田薬品工業株式会社 | 芳香環化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1206403A (en) * | 1966-12-15 | 1970-09-23 | Wyeth John & Brother Ltd | Oxazoles |
| US3578671A (en) * | 1967-11-06 | 1971-05-11 | Wyeth John & Brother Ltd | Oxazoles |
| DE2129012A1 (de) * | 1971-06-11 | 1973-01-04 | Merck Patent Gmbh | Azol-derivate |
| US3895115A (en) * | 1974-03-01 | 1975-07-15 | Serono Ist Farm | Method of inhibiting platelet aggregation |
| GB1507032A (en) * | 1974-08-06 | 1978-04-12 | Serono Lab | 2-thiol-4,5-diphenyloxazole s-derivatives |
-
1990
- 1990-12-14 NZ NZ236474A patent/NZ236474A/xx unknown
- 1990-12-17 FI FI906213A patent/FI906213A/fi not_active Application Discontinuation
- 1990-12-18 NO NO90905444A patent/NO905444L/no unknown
- 1990-12-19 KR KR1019900021064A patent/KR910011810A/ko not_active Application Discontinuation
- 1990-12-19 CA CA002032674A patent/CA2032674A1/en not_active Abandoned
- 1990-12-19 CN CN90110135A patent/CN1028173C/zh not_active Expired - Fee Related
- 1990-12-19 PT PT96276A patent/PT96276A/pt not_active Application Discontinuation
- 1990-12-19 EP EP90124776A patent/EP0434034A1/en not_active Ceased
- 1990-12-20 YU YU240990A patent/YU240990A/sh unknown
- 1990-12-20 IL IL96747A patent/IL96747A0/xx unknown
- 1990-12-20 HU HU908361A patent/HU206100B/hu not_active IP Right Cessation
- 1990-12-20 JP JP2419324A patent/JPH04217966A/ja active Pending
-
1992
- 1992-05-22 HU HU9201706A patent/HU9201706D0/hu unknown
-
1994
- 1994-04-12 CN CN94104206A patent/CN1101042A/zh active Pending
- 1994-04-12 CN CN94104211A patent/CN1101043A/zh active Pending
- 1994-04-12 CN CN94104210A patent/CN1101041A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1101043A (zh) | 1995-04-05 |
| HU908361D0 (en) | 1991-07-29 |
| HU206100B (en) | 1992-08-28 |
| CN1101042A (zh) | 1995-04-05 |
| CN1052667A (zh) | 1991-07-03 |
| HUT59116A (en) | 1992-04-28 |
| YU240990A (sh) | 1992-12-21 |
| FI906213A0 (fi) | 1990-12-17 |
| HU9201706D0 (en) | 1992-08-28 |
| JPH04217966A (ja) | 1992-08-07 |
| FI906213A (fi) | 1991-06-21 |
| NO905444D0 (no) | 1990-12-18 |
| EP0434034A1 (en) | 1991-06-26 |
| CN1028173C (zh) | 1995-04-12 |
| NO905444L (no) | 1991-06-21 |
| NZ236474A (en) | 1993-07-27 |
| CN1101041A (zh) | 1995-04-05 |
| CA2032674A1 (en) | 1991-06-21 |
| KR910011810A (ko) | 1991-08-07 |
| PT96276A (pt) | 1991-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ233320A (en) | 3-substituted-2-oxo-indole derivatives and pharmaceutical compositions | |
| IL95351A0 (en) | 17beta-acyl-4-aza-5alpha-androst-1-en-3-ones and pharmaceutical compositions containing them | |
| IL90067A0 (en) | 1alpha-hydroxyvitamin-d compounds and pharmaceutical compositions containing them | |
| IL88988A0 (en) | Didehydro-vitamin d3 derivatives and pharmaceutical compositions containing them | |
| NZ220345A (en) | Imidazoquinolinylether derivatives and pharmaceutical compositions containing them | |
| NZ220880A (en) | Di-tert-butyl-phenol derivatives and pharmaceutical compositions | |
| NZ225398A (en) | Oxadiazole derivatives and pharmaceutical compositions | |
| PH27603A (en) | Phenol substituted gemdiphosphonate derivatives and pharmaceutical compositions containing them | |
| NZ221996A (en) | Imidazo-pyridine derivatives and pharmaceutical compositions | |
| NZ220171A (en) | Dihydro-benzopyran derivatives and pharmaceutical compositions | |
| NZ233790A (en) | Benzocycloalkane derivatives and pharmaceutical compositions | |
| NZ233011A (en) | Thieno-triazole-diazepine and pharmaceutical compositions | |
| HU896612D0 (en) | Process for the preparation of 2-iminebenzothiazole derivatives and pharmaceutical compositions thereof | |
| HU896479D0 (en) | Process for the preparation of capsaycin derivatives and pharmaceutical compositions thereof | |
| IL96747A0 (en) | Oxazole derivatives and pharmaceutical compositions containing them | |
| NZ236483A (en) | Glycerol derivatives and pharmaceutical compositions thereof | |
| NZ228812A (en) | Quinolazine derivatives; pharmaceutical compositions and preparatory processes | |
| NZ217871A (en) | Oxazole derivatives and pharmaceutical compositions | |
| NZ234174A (en) | Dihydroindenoindole derivatives and compositions containing them | |
| NZ232701A (en) | Substituted benzoxazolinone derivatives and pharmaceutical compositions | |
| NZ225613A (en) | Benzazepin-2-one derivatives and pharmaceutical compositions | |
| NZ233013A (en) | Substituted thieno-triazolo-diazepine derivatives and pharmaceutical compositions | |
| IL89155A0 (en) | Ouabain-like compounds and pharmaceutical compositions containing them | |
| NZ223051A (en) | Carbamoyloxylabdane derivatives and pharmaceutical compositions | |
| KR960009424B1 (en) | Rhodanine derivatives and pharmaceutical compositions |